Laser & Skin Surgery Center of New York, New York.
Department of Dermatology, Weill Cornell Medical Center, New York, New York.
JAMA Dermatol. 2019 Apr 1;155(4):435-441. doi: 10.1001/jamadermatol.2018.5249.
Recent concerns regarding repetitive use of general anesthesia in children younger than 3 years have placed greater importance on the controversy surrounding the timing of the initiation of port-wine stain (PWS) laser treatment.
To evaluate the use of PWS treatments at the age of 1 year or younger in the office setting without general anesthesia.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study based on medical record reviews at a single, high-volume laser center for children who started pulsed dye laser treatment at the age of 1 year or younger for their PWS between 2000 and 2017. The data cutoff was at 1 year after the initial treatment to have comparable data points.
The primary outcome was improvement of PWSs using before and after photographs, which were reviewed by 4 physicians independently and graded using the following 5-point visual analog scale (VAS): poor (grade 1: 0%-25% improvement), fair (grade 2: 26%-50% improvement), good (grade 3: 51%-75% improvement), excellent (grade 4: 76%-99% improvement), and complete (grade 5: 100% improvement) clearance.
Of the 197 patients (73 [37.1%] boys; 124 [62.9%] girls), most (149 [75.6%]) had facial lesions. The mean age at the time of first treatment was 3.38 months (range, 5-355 days) and the mean number of treatments was 9.8 (range, 2-23; median, 10). Per the mean physician VAS grading of 197 patients, 51 patients (25.9%) showed 100% clearance (mean [range] VAS score of 4.78 [4.5 - 5]); 81 patients (41.1%) showed 76 to 99% improvement (mean [range] VAS score of 3.91 [3.5 to <4.5]); 44 patients (22.3%) showed 51% to 75% improvement (mean [range] VAS score of 2.86 [2.5 to <3.5]); 13 patients (6.6%) showed 26% to 50% improvement (mean [range] VAS score of 2.12 [1.5 to <2.5]); and 8 patients (4.1%) showed 0 to 25% improvement (mean [range] VAS score of 0.78 [0 to <1.5]). The presence of a V1 (first branch of the trigeminal nerve [ophthalmic nerve]) lesion was associated with a statistically significantly higher clearance rate by a VAS grade of 0.55 (95% CI, 0.25-0.84; P < .001). The mean (SD) VAS grade for all patients was 3.65 (1.26), corresponding to excellent clearance. None of the patients experienced scarring or permanent pigmentary change.
In this study, treatment of PWSs in infancy was both safe and effective. Early intervention allows for treatment without general anesthesia, maximizing the chance to achieve clearance before school age and thereby minimizing the negative outcome of PWSs for both the patient and the family.
最近人们对 3 岁以下儿童反复使用全身麻醉的担忧,使得围绕葡萄酒色斑(PWS)激光治疗开始时间的争议更加重要。
评估在办公室环境中,1 岁以下儿童无需全身麻醉即可进行 PWS 治疗。
设计、地点和参与者:这是一项基于病历回顾的回顾性队列研究,在一家高容量的儿童激光中心进行,该中心在 2000 年至 2017 年间,对 1 岁及以下因 PWS 接受脉冲染料激光治疗的儿童,在 1 岁时开始进行 PWS 治疗。数据截止时间为初次治疗后 1 年,以便获得可比的数据点。
主要结局是使用治疗前后的照片评估 PWS 的改善情况,由 4 位医生独立进行评估,并使用以下 5 分视觉模拟量表(VAS)进行分级:差(1 级:改善 0%-25%)、一般(2 级:改善 26%-50%)、好(3 级:改善 51%-75%)、优秀(4 级:改善 76%-99%)和完全(5 级:改善 100%)。
在 197 名患者(73 名男孩[37.1%];124 名女孩[62.9%])中,大多数(149 名[75.6%])有面部病变。首次治疗时的平均年龄为 3.38 个月(范围,5-355 天),平均治疗次数为 9.8 次(范围,2-23 次;中位数,10 次)。根据 197 名患者的平均医生 VAS 分级,51 名患者(25.9%)达到 100%清除(平均[范围] VAS 评分为 4.78 [4.5-5]);81 名患者(41.1%)达到 76%-99%改善(平均[范围] VAS 评分为 3.91 [3.5-<4.5]);44 名患者(22.3%)达到 51%-75%改善(平均[范围] VAS 评分为 2.86 [2.5-<3.5]);13 名患者(6.6%)达到 26%-50%改善(平均[范围] VAS 评分为 2.12 [1.5-<2.5]);8 名患者(4.1%)达到 0%-25%改善(平均[范围] VAS 评分为 0.78 [0-<1.5])。存在 V1(三叉神经第一分支[眼神经])病变与 VAS 分级 0.55(95%CI,0.25-0.84;P<.001)的清除率呈统计学显著相关。所有患者的平均(SD)VAS 评分为 3.65(1.26),对应优秀清除率。所有患者均未出现瘢痕或永久性色素改变。
在这项研究中,婴儿期 PWS 的治疗既安全又有效。早期干预可以在无需全身麻醉的情况下进行治疗,最大限度地提高患者在上学前达到清除的机会,从而最大限度地减少 PWS 对患者及其家庭的负面影响。